Chakravarty et al. [179] have investigated the effect of nelfinavir, an HIV protease inhibitor (also known as P-gp substrate [180]) on doxorubicin toxicity in an MDR breast cancer cell line. The gene discussed is PGP; the disease is breast cancer.